Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Scryb Inc RYMDF


Primary Symbol: C.SCYB Alternate Symbol(s):  SCYRF

Scryb Inc. is a technology company that provides its platform to power businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The Company’s technologies include Cybeats, FRR, and Pharmatrac. Cybeats is an integrated security platform designed to secure and protect high-valued connected devices. The Fionet Platform is an end-to-end, rapid testing and tracking solution for community-based or decentralized settings. Combining a fast, handheld point-of-need device connected in real time to cloud data services, the Fionet Platform handles scheduling and registration via phone app at home, on-site check-in, rapid, on-the-spot antigen testing, and anonymized data and stats for dashboards for authorized stakeholders. Pharmatrac, an AI healthcare company, provides insight into medication behavior. The Company’s platform enables customers across industries to create, enhance and power disruptive solutions.


CSE:SCYB - Post by User

Comment by VerusSemperSorson Jun 27, 2021 4:41pm
100 Views
Post# 33457895

RE:RE:RE:NEWS!

RE:RE:RE:NEWS!No doubt 24 million would have been better, but would it make sense to spend that much cash? They raised $3 million if February from the exercise of warrants & options. 12 million shares bought back at $0.25 or a bit less would just about use that up.

That would leave the proceeds of the January PP untouched by the share buy back. It wouldn't make much sense to do a PP just to end up buying back shares with the proceeds. I'm thinking that buying back more than 12 million shares would have been very hard to justify with the cash available to them.

Maybe 12 million max buy back plus some insider buying will be enough to get us moving up again?


goldens wrote: Its only 12 million shares max. 240 million outstanding. 5%. 24 million would have been better.It does also say "maximum" in the news release so it doesn't mean they will even purchase a single share. They need to get the pilot done and get into more airports or get more clients and find other applications of the tech.


<< Previous
Bullboard Posts
Next >>